Tech Company Financing Transactions

Horizon Pharma Funding Round

On 7/24/2007, Horizon Pharma landed $30 million in Series C investment from EW Healthcare Partners, FirstMark Capital and Scale Venture Partners.

Transaction Overview

Company Name
Announced On
7/24/2007
Transaction Type
Venture Equity
Amount
$30,000,000
Round
Series C
Investors
Proceeds Purpose
"This financing will take us through to clinical data and, if successful, the new drug application filing of HZT-501, while also enabling us to advance our second product candidate HZT-602 into Phase 3 trials," said George F. Tidmarsh, M.D., Ph.D., co-founder and chief executive officer of Horizon Therapeutics. "We initiated our pivotal studies for HZT-501 earlier this year and are on track to complete enrollment in 2008."

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
150 South Wacker Dr. 3200
Chicago, IL 60606
USA
Email Address
Overview
A company passionate about improving the treatment of arthritis and pain for the relief of signs and symptoms of rheumatoid arthritis and osteoarthritis.
Profile
Horizon Pharma LinkedIn Company Profile
Social Media
Horizon Pharma Company Twitter Account
Company News
Horizon Pharma News
Facebook
Horizon Pharma on Facebook
YouTube
Horizon Pharma on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Timothy Walbert
  Timothy Walbert LinkedIn Profile  Timothy Walbert Twitter Account  Timothy Walbert News  Timothy Walbert on Facebook
Chief Financial Officer
Paul Hoelscher
  Paul Hoelscher LinkedIn Profile  Paul Hoelscher Twitter Account  Paul Hoelscher News  Paul Hoelscher on Facebook
Chief Medical Officer
Jeffrey Sherman
  Jeffrey Sherman LinkedIn Profile  Jeffrey Sherman Twitter Account  Jeffrey Sherman News  Jeffrey Sherman on Facebook
Chief Scientific Officer
Shao-Lee Lin
  Shao-Lee Lin LinkedIn Profile  Shao-Lee Lin Twitter Account  Shao-Lee Lin News  Shao-Lee Lin on Facebook
VP - Administration
Barry Moze
  Barry Moze LinkedIn Profile  Barry Moze Twitter Account  Barry Moze News  Barry Moze on Facebook
VP - Bus. Development
Robert Carey
  Robert Carey LinkedIn Profile  Robert Carey Twitter Account  Robert Carey News  Robert Carey on Facebook
VP - General Counsel
Brian Beeler
  Brian Beeler LinkedIn Profile  Brian Beeler Twitter Account  Brian Beeler News  Brian Beeler on Facebook
VP - Human Resources
Irina Konstantinovsky
  Irina Konstantinovsky LinkedIn Profile  Irina Konstantinovsky Twitter Account  Irina Konstantinovsky News  Irina Konstantinovsky on Facebook


 

 

Browse more venture capital transactions:

Prev: 7/24/2007: Lessno venture capital transaction
Next: 7/24/2007: deCarta venture capital transaction

 

Share this article

 


Where The Data Comes From

Our team works diligently to report on every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary